- Home
- PBBK vs ACXP Comparison
PBBK vs ACXP Comparison
Compare PBBK & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- ACXP
- Stock Information
- Founded
- PBBK 1919
- ACXP 2017
- Country
- PBBK United States
- ACXP United States
- Employees
- PBBK N/A
- ACXP N/A
- Industry
- PBBK Banks
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- PBBK Finance
- ACXP Health Care
- Exchange
- PBBK Nasdaq
- ACXP Nasdaq
- Market Cap
- PBBK 45.2M
- ACXP 8.4M
- IPO Year
- PBBK N/A
- ACXP 2021
- Fundamental
- Price
- PBBK $18.42
- ACXP $0.43
- Analyst Decision
- PBBK
- ACXP Strong Buy
- Analyst Count
- PBBK 0
- ACXP 2
- Target Price
- PBBK N/A
- ACXP $10.00
- AVG Volume (30 Days)
- PBBK 23.3K
- ACXP 18.7M
- Earning Date
- PBBK 08-13-2025
- ACXP 08-08-2025
- Dividend Yield
- PBBK N/A
- ACXP N/A
- EPS Growth
- PBBK 12.16
- ACXP N/A
- EPS
- PBBK 0.83
- ACXP N/A
- Revenue
- PBBK $12,804,000.00
- ACXP N/A
- Revenue This Year
- PBBK N/A
- ACXP N/A
- Revenue Next Year
- PBBK N/A
- ACXP N/A
- P/E Ratio
- PBBK $22.61
- ACXP N/A
- Revenue Growth
- PBBK 5.21
- ACXP N/A
- 52 Week Low
- PBBK $14.05
- ACXP $0.30
- 52 Week High
- PBBK $19.12
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- PBBK 57.84
- ACXP 46.13
- Support Level
- PBBK $18.40
- ACXP $0.45
- Resistance Level
- PBBK $18.85
- ACXP $0.59
- Average True Range (ATR)
- PBBK 0.58
- ACXP 0.07
- MACD
- PBBK 0.04
- ACXP -0.01
- Stochastic Oscillator
- PBBK 62.57
- ACXP 10.73
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.